New potassium binders reduce the risk of hyperkalaemia in patients treated with renin-angiotensin-aldosterone system inhibitors.

Tamargo M, Tamargo J. New potassium binders reduce the risk of hyperkalaemia in patients treated with renin-angiotensin-aldosterone system inhibitors. Eur Heart J Cardiovasc Pharmacother. 2018 10 01; 4(4):193-194.

View in: PubMed

subject areas

Angiotensin-Converting Enzyme Inhibitors
Chelating Agents
Humans
Hyperkalemia
Polymers
Potassium
Renin-Angiotensin System
Risk Factors
Silicates
Treatment Outcome

authors with profiles

Maria C. Tamargo

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support